Author

Annemieke J.M. Nieuweboer

Observed names: A J M Nieuweboer, A. Nieuweboer, A.J.M. Nieuweboer, Annemieke J. M. Nieuweboer, Annemieke JM Nieuweboer, Annemieke Nieuweboer

Observed institutions: Uppsala University, St. Jude Children's Research Hospital, Erasmus MC, University of Kansas Medical Center, Erasmus MC Cancer Institute, Daniel den Hoed Kliniek

OpenAlex ID: A5031865542

Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells

2015 · Wendy Onstenk, Anieta M. Sieuwerts, et al. · European Urology · 236

Markers Predicting Response to Bacillus Calmette-Guérin Immunotherapy in High-Risk Bladder Cancer Patients: A Systematic Review

2011 · Tahlita C.M. Zuiverloon, Annemieke J.M. Nieuweboer, et al. · European Urology · 177

The influence of prior novel androgen receptor targeted therapy on the efficacy of cabazitaxel in men with metastatic castration-resistant prostate cancer

2015 · R.J. van Soest, A.J.M. Nieuweboer, et al. · European Journal of Cancer · 61

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

2014 · Annemieke J.M. Nieuweboer, Shuiying Hu, et al. · Cancer Research · 60

PDF

CYP3A4Intron 6 C>T SNP (CYP3A4*22) Encodes Lower CYP3A4 Activity in Cancer Patients, as Measured with Probes Midazolam and Erythromycin

2013 · Laure Elens, Annemieke Nieuweboer, et al. · Pharmacogenomics · 60

Combinations of Urinary Biomarkers for Surveillance of Patients with Incident Nonmuscle Invasive Bladder Cancer: The European FP7 UROMOL Project

2012 · Tahlita C.M. Zuiverloon, Willemien Beukers, et al. · The Journal of Urology · 54

Inter-patient variability in docetaxel pharmacokinetics: A review

2015 · Annemieke J.M. Nieuweboer, Ellen S. de Morrée, et al. · Cancer Treatment Reviews · 47

Impact of POR*28 on the clinical pharmacokinetics of CYP3A phenotyping probes midazolam and erythromycin

2013 · Laure Elens, Annemieke J.M. Nieuweboer, et al. · Pharmacogenetics and Genomics · 43

Quantification of cabazitaxel in human plasma by liquid chromatography/triple-quadrupole mass spectrometry: A practical solution for non-specific binding

2011 · Peter de Bruijn, Anne-Joy M. de Graan, et al. · Journal of Pharmaceutical and Biomedical Analysis · 36

AR splice variants in circulating tumor cells of patients with castration‐resistant prostate cancer: relation with outcome to cabazitaxel

2019 · Anieta M. Sieuwerts, Wendy Onstenk, et al. · Molecular Oncology · 29

PDF

Prognostic factors in men with metastatic castration-resistant prostate cancer treated with cabazitaxel

2017 · Bodine P.S. Belderbos, Ronald de Wit, et al. · Oncotarget · 29

PDF

Pharmacokinetically based dosing of weekly paclitaxel to reduce drug-related neurotoxicity based on a single sample strategy

2015 · Stefanie Kraff, Annemieke J. M. Nieuweboer, et al. · Cancer Chemotherapy and Pharmacology · 23

A Pharmacogenetic Predictive Model for Paclitaxel Clearance Based on the DMET Platform

2013 · Anne-Joy M. de Graan, Laure Elens, et al. · Clinical Cancer Research · 23

Role of genetic variation in docetaxel-induced neutropenia and pharmacokinetics

2015 · A J M Nieuweboer, M Smid, et al. · The Pharmacogenomics Journal · 17

Predicting Paclitaxel-Induced Neutropenia Using the DMET Platform

2015 · Annemieke JM Nieuweboer, Marcel Smid, et al. · Pharmacogenomics · 17

Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study

2016 · Annemieke J.M. Nieuweboer, Anne-Joy M. de Graan, et al. · Clinical Cancer Research · 12

Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer

2018 · Bo Gao, Yi Lu, et al. · Scientific Reports · 8

PDF

Association between Paclitaxel Clearance and Tumor Response in Patients with Esophageal Cancer

2019 · Eelke L.A. Toxopeus, Femke M. de Man, et al. · Cancers · 1

PDF

A randomized phase II multicenter trial on the effects of budesonide on cabazitaxel-induced diarrhea: CABARESC.

2016 · Sander Bins, Annemieke J.M. Nieuweboer, et al. · Journal of Clinical Oncology · 1

A pharmacogenetic model predicting low paclitaxel clearance based on the DMET platform.

2013 · Annemieke J.M. Nieuweboer, Anne-Joy M. de Graan, et al. · Journal of Clinical Oncology · 1

Supplementary Table 4 from Effects of Budesonide on Cabazitaxel Pharmacokinetics and Cabazitaxel-Induced Diarrhea: A Randomized, Open-Label Multicenter Phase II Study